Register

Downloads / CME Credit

Chair & Presenters

Ruben A. Mesa, MD, FACP
Chair and Presenter
Ruben A. Mesa, MD, FACP
UT Health San Antonio Cancer Center
San Antonio, Texas
Nicolaus Kröger, MD
Presenter
Nicolaus Kröger, MD
University Hospital Hamburg-Eppendorf
Hamburg, Germany
Francesco Passamonti, MD
Presenter
Francesco Passamonti, MD
University of Insubria
Varese, Italy
Robyn M. Scherber, MD
Presenter
Robyn M. Scherber, MD
Mayo Clinic in Arizona
Phoenix, Arizona

Location

Hyatt Regency Atlanta
Regency VII — Registration and Lunch
Regency VI — Symposium
265 Peachtree Street, NE
Atlanta, GA 30303

Agenda

12:30 PM EST  Registration & Lunch

1:00 PM EST    Welcome and Thoughts on MPN Care in the Modern Era

1:10 PM EST    MPN Casebook 1: Capturing Elusive PV Presentations: An Under-Recognized Problem?

1:35 PM EST    MPN Casebook 2: Targeting Uncontrolled PV: From Recognition to Treatment

2:00 PM EST    MPN Casebook 3: Initial Treatment Choices in MF, Risk Models, and Symptom Burden

2:25 PM EST    MPN Casebook 4: Allogeneic Transplant in PMF During the JAK Inhibitor Era

2:50 PM EST    Take-Home Thoughts and Audience Q&A

3:00 PM EST    Adjourn

CME Information

Activity Description & Educational Objectives

Philadelphia-chromosome–negative myeloproliferative neoplasms (MPNs) are increasingly recognized as a complex set of disorders that require nuanced approaches to disease recognition, treatment selection, and therapeutic sequencing. This change is fueled by new insights into disease biology for disorders such as polycythemia vera (PV) and myelofibrosis (MF), and the availability of novel, effective therapeutic options such as JAK inhibitors, including for patients who may not present with “classic” disease features at baseline or at any point along the disease continuum.

PeerView will explore these exciting developments in an integrated live/on-demand educational initiative anchored by a Friday Satellite Symposium at the 2017 ASH Annual Meeting. This CME-certified activity will utilize the PeerView Live Casebook format, offering learners a collection of patient stories detailing clinical decision points in key treatment settings in PV and MF, paired with an analysis of the latest evidence on disease management. The cases will also feature point-by-point illustrations of how challenging MPN presentations can be effectively managed with available options despite falling outside of standard characterizations of PV or MF. Learners will also receive case summaries as point of care tools to guide management of MPNs not corresponding to conventional clinical consensus.

Upon completion of this activity, participants should be better able to:

Target Audience

This activity has been designed to meet the educational needs of hematologist-oncologists, hematologists, oncologists, advanced practice oncology nurses, and other healthcare professionals involved in the care of patients with MPN.

Requirements for Successful Completion

In order to receive credit, participants must attend the live activity and complete the request for credit. There are no prerequisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon completion of the request for credit at the end of the post-test.

Media: Symposium
Release and Expiration Date: December 8, 2017
Time to Complete: 120 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity during the past 12 months.

Chair and Presenter

Ruben A. Mesa, MD, FACP
Director, UT Health San Antonio Cancer Center
Mays Family Foundation Distinguished University Presidential Chair
San Antonio, Texas

Presenters

Nicolaus Kröger, MD
Professor of Medicine
Director
Department of Stem Cell Transplantation
University Hospital Hamburg-Eppendorf
Hamburg, Germany

Francesco Passamonti, MD
Head Hematology
Department of Medicine and Surgery
University of Insubria
Varese, Italy

Robyn M. Scherber, MD
Mayo Clinic in Arizona
Phoenix, Arizona

Medical Director

Aarati Ranganathan, PhD
PVI, PeerView Institute for Medical Education

Disclaimer

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Providership

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an educational grant from Incyte Corporation.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

We invite you to attend our other symposia while at the conference. For our Friday dinner symposia, register here: peerviewpress.com/ALL17, or here: peerviewpress.com/HemA17.